Breakthrough Medical Devices and Biopharmaceuticals

Home >> Useful Info >> Life Sciences in Israel >> Breakthrough Medical Devices and Biopharmaceuticals
Israel’s breakthroughs are often a result of several converging technologies including physics, mathematics, computer sciences, nanotechnology and others.
  • Pillcam, the first miniature ingested camera which diagnoses and photographs abnormalities in the gastrointestinal tract was introduced by Given Imaging.
  • Galil Medical's minimally invasive cryotherapy solutions freeze and ablate benign cancerous tissue, thereby hastening a patient's' recovery.
  • Teva's Copaxone for the treatment of Multiple Sclerosis and Azilect for Parkinson's disease are revolutionary drugs developed in Israel.
  • Medinol's closed cell stent is used worldwide for heart catheterization.
  • Rebif, a treatment for Central Nervous System disorders was developed by the Weizmann Institute and Serono.
  • Insightec developed the ExAblate 2000 non-invasive surgery, which uses MR guided focused ultrasound to treat uterine fibroids.(Pictured: ExAblate procedure courtesy of Insightec)
  • Exelon, a drug for the treatment of Alzheimer's originated at the Hebrew University and was developed and marketed by Novartis.
  • A chemotherapy drug for the treatment of ovarian cancer, Doxil, was developed at the Hadassah Medical Center and sold to Johnson & Johnson.
  • Microneedle based systems for the painless intradermal delivery of drugs was implemented by NanoPass which collaborated with GlaxoSmithKline on optimization of its platform for vaccine delivery.

Source: Invest In Israel